Axion BioSystems Maestro Volt Microelectrode Array System

Overview

The Axion BioSystems Maestro Volt Microelectrode Array (MEA) System is an entry-tier, high-fidelity electrophysiology platform engineered for robust, label-free, real-time recording of extracellular electrical activity from intact, functional neural and cardiac networks in vitro. Based on the established Couette-style planar electrode architecture, the Maestro Volt utilizes a 384-electrode grid embedded in the bottom of standard multi-well plates (e.g., 96-well format), enabling simultaneous, non-invasive detection of spontaneous and evoked action potentials with millisecond temporal resolution and spatial mapping across multiple biological replicates. Unlike indirect assays—such as calcium imaging or immunoblotting—the Maestro Volt directly measures voltage transients generated by ion channel flux, providing physiologically relevant functional readouts that correlate strongly with network-level excitability, synaptic integrity, and rhythmic oscillatory behavior. The system operates within a controlled environmental chamber (maintaining 37 °C and 5% CO₂), ensuring physiological stability during longitudinal experiments spanning hours to weeks.

Key Features

• 384-channel high-density MEA plate: Enables parallel recording from up to 96 wells (4 electrodes per well), supporting statistically powered, multi-condition screening without sacrificing spatial resolution.
• Label-free & non-invasive operation: Eliminates requirement for dyes, reporters, or genetic modification—preserving native cell morphology, viability, and network architecture over extended durations.
• In situ network monitoring: Records from intact monolayers, co-cultures, brain slices, and 3D organoids—without enzymatic dissociation or mechanical disruption required by patch-clamp or flow cytometry platforms.
• Integrated environmental control: Onboard temperature regulation and gas mixing ensure stable physiological conditions during long-term recordings (≥14 days demonstrated).
• Modular software analysis: AxIS Navigator software provides automated quantification of three core neurophysiological dimensions: Activity (spike rate, burst frequency), Synchrony (cross-correlation, joint entropy), and Oscillation (power spectral density, dominant frequency bands).
• Regulatory-ready data handling: Software supports audit trails, user access controls, and electronic signatures compliant with GLP and FDA 21 CFR Part 11 requirements for preclinical safety pharmacology studies.

Sample Compatibility & Compliance

The Maestro Volt is validated for use with primary rodent and human neurons, iPSC-derived neuronal and cardiomyocyte cultures, acute brain and spinal cord slices, and complex 3D models including cerebral organoids, cardiac spheroids, and neuromuscular co-cultures. All MEA plates are manufactured under ISO 13485-certified cleanroom conditions and sterilized via gamma irradiation. The system meets IEC 61000-4 electromagnetic compatibility standards and complies with UL/CSA safety regulations for laboratory instrumentation. For regulatory submissions, raw data files (binary .axd format) and processed metrics are exportable in CSV, HDF5, and MATLAB-compatible formats, facilitating traceability and third-party validation.

Software & Data Management

AxIS Navigator v3.x serves as the primary acquisition and analysis interface, offering both guided workflows for novice users and scriptable pipelines for advanced customization via Python API. The software automatically computes >25 secondary parameters—including inter-spike interval variability, burst duration, network burst index, and phase-locking value—enabling deep phenotypic profiling. All processing steps are logged with timestamps, operator ID, and parameter settings. Data archives support version-controlled storage with SHA-256 checksum verification. Optional integration with Axion’s Omni Cloud platform enables secure remote collaboration, centralized metadata tagging, and AI-assisted anomaly detection across multi-site studies.

Applications

• Functional characterization of iPSC-derived disease models (e.g., Parkinson’s, Rett syndrome, Dravet syndrome)
• High-throughput neurotoxicity screening per OECD TG 426 and ICH S7B guidelines
• Pharmacological profiling of CNS-active compounds, including modulators of Na⁺, K⁺, Ca²⁺, and GABA_A channels
• Longitudinal assessment of neural maturation, synaptic pruning, and network homeostasis
• Validation of CRISPR-edited isogenic lines and bioprocess consistency in stem cell manufacturing
• Combined optogenetic-electrophysiological interrogation using integrated Lumos stimulation modules (4-wavelength LED array, 100 ms pulse resolution)
• Multi-parametric phenotyping of glial-neuronal interactions and inflammatory modulation of network excitability

FAQ

What sample types are compatible with the Maestro Volt?
Primary neurons, iPSC-derived neurons and cardiomyocytes, acute brain slices (200–400 µm), cortical spheroids, forebrain organoids, and co-cultures with astrocytes or microglia.
Can the Maestro Volt be used for cardiac electrophysiology?
Yes—neuro and cardiac analysis modules are available separately; the cardiac module includes beat period variability, field potential duration (FPD), and triangulation metrics aligned with CiPA initiative standards.
Is the system compatible with existing Axion MEA plates?
Yes—Maestro Volt accepts all Axion-branded 48-, 96-, and 384-well MEA plates, including those pre-coated with laminin, poly-D-lysine, or custom ECM formulations.
How is data integrity ensured during long-term experiments?
Continuous environmental monitoring (temperature, CO₂, humidity), hardware-level signal calibration before each run, and automatic drift correction algorithms maintain baseline stability across multi-week acquisitions.
Does the system support GLP-compliant study execution?
Yes—AxIS Navigator includes full 21 CFR Part 11 compliance features: role-based permissions, electronic signatures, immutable audit logs, and data encryption at rest and in transit.